{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:41:38Z","timestamp":1791499298226,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006578","name":"Chi Mei Medical Center","doi-asserted-by":"publisher","award":["106CM-TMU-10"],"award-info":[{"award-number":["106CM-TMU-10"]}],"id":[{"id":"10.13039\/501100006578","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.cbi.2019.01.033","type":"journal-article","created":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T16:31:35Z","timestamp":1548693095000},"page":"28-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["The antipsychotic chlorpromazine suppresses YAP signaling, stemness properties, and drug resistance in breast cancer cells"],"prefix":"10.1016","volume":"302","author":[{"given":"Chang-En","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ying","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Wei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu-Hung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Lowng","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2019.01.033_bib1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/00001622-200111000-00002","article-title":"Breast cancer epidemiology, prevention, and early detection","volume":"13","author":"Brewster","year":"2001","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.cbi.2019.01.033_bib2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1158\/1541-7786.MCR-05-0192","article-title":"The role of the BRCA1 tumor suppressor in DNA double-strand break repair","volume":"3","author":"Zhang","year":"2005","journal-title":"Mol. Canc. Res."},{"key":"10.1016\/j.cbi.2019.01.033_bib3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.molcel.2015.10.031","article-title":"Breast tumor heterogeneity: source of fitness, hurdle for therapy","volume":"60","author":"Koren","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cbi.2019.01.033_bib4","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00018-016-2334-7","article-title":"Breast cancer stem cell: the roles and therapeutic implications","volume":"74","author":"Yang","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cbi.2019.01.033_bib5","first-page":"435","article-title":"Cancer stem cells","volume":"52","author":"Soltysova","year":"2005","journal-title":"Neoplasma"},{"key":"10.1016\/j.cbi.2019.01.033_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19124036","article-title":"Targeting cancer stem cells to overcome chemoresistance","volume":"19","author":"Nunes","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2019.01.033_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.yexmp.2015.11.032","article-title":"ALDH(+)\/CD44(+) cells in breast cancer are associated with worse prognosis and poor clinical outcome","volume":"100","author":"Qiu","year":"2016","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.cbi.2019.01.033_bib8","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1111\/j.1582-4934.2008.00455.x","article-title":"High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability","volume":"13","author":"Croker","year":"2009","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.cbi.2019.01.033_bib9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","article-title":"ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome","volume":"1","author":"Ginestier","year":"2007","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.cbi.2019.01.033_bib10","first-page":"3224","article-title":"Yes-associated protein (YAP) is differentially expressed in tumor and stroma according to the molecular subtype of breast cancer","volume":"7","author":"Kim","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.cbi.2019.01.033_bib11","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.ejca.2011.10.001","article-title":"Yes-associated protein promotes tumour development in luminal epithelial derived breast cancer","volume":"48","author":"Wang","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.cbi.2019.01.033_bib12","first-page":"83","article-title":"The role of Hippo pathway in cancer stem cell biology","volume":"41","author":"Park","year":"2018","journal-title":"Mol. Cell."},{"key":"10.1016\/j.cbi.2019.01.033_bib13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","article-title":"YAP\/TAZ at the roots of cancer","volume":"29","author":"Zanconato","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cbi.2019.01.033_bib14","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/onc.2014.5","article-title":"TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells","volume":"34","author":"Bartucci","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.cbi.2019.01.033_bib15","doi-asserted-by":"crossref","first-page":"13461","DOI":"10.1074\/jbc.M113.529115","article-title":"The transcriptional regulators TAZ and YAP direct transforming growth factor beta-induced tumorigenic phenotypes in breast cancer cells","volume":"289","author":"Hiemer","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2019.01.033_bib16","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/embj.201386082","article-title":"Tumor-propagating cells and Yap\/Taz activity contribute to lung tumor progression and metastasis","volume":"33","author":"Lau","year":"2014","journal-title":"EMBO J."},{"key":"10.1016\/j.cbi.2019.01.033_bib17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2017.07.013","article-title":"Drug repurposing in cancer","volume":"124","author":"Sleire","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cbi.2019.01.033_bib18","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/CAD.0b013e32832ec041","article-title":"The antipsychotic drug chlorpromazine enhances the cytotoxic effect of tamoxifen in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells","volume":"20","author":"Yde","year":"2009","journal-title":"Anti Canccer Drugs"},{"key":"10.1016\/j.cbi.2019.01.033_bib19","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1093\/carcin\/bgt169","article-title":"The antipsychotic agent chlorpromazine induces autophagic cell death by inhibiting the Akt\/mTOR pathway in human U-87MG glioma cells","volume":"34","author":"Shin","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cbi.2019.01.033_bib20","doi-asserted-by":"crossref","first-page":"27580","DOI":"10.18632\/oncotarget.4768","article-title":"Repositioning antipsychotic chlorpromazine for treating colorectal cancer by inhibiting sirtuin 1","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.cbi.2019.01.033_bib21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ejmech.2018.03.055","article-title":"Repositioning of the antipsychotic trifluoperazine: synthesis, biological evaluation and in silico study of trifluoperazine analogs as anti-glioblastoma agents","volume":"151","author":"Kang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2019.01.033_bib22","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1164\/rccm.201207-1180OC","article-title":"Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer","volume":"186","author":"Yeh","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cbi.2019.01.033_bib23","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/ijc.30888","article-title":"Panobinostat sensitizes KRAS-mutant non-small-cell lung cancer to gefitinib by targeting TAZ","volume":"141","author":"Lee","year":"2017","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.cbi.2019.01.033_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102047","article-title":"Podocalyxin-like protein 1 regulates TAZ signaling and stemness properties in colon cancer","volume":"18","author":"Lee","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2019.01.033_bib25","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature03799","article-title":"Genes that mediate breast cancer metastasis to lung","volume":"436","author":"Minn","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2019.01.033_bib26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1186\/1471-2407-10-539","article-title":"Genome profiling of ERBB2-amplified breast cancers","volume":"10","author":"Sircoulomb","year":"2010","journal-title":"BMC Canc."},{"key":"10.1016\/j.cbi.2019.01.033_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027656","article-title":"Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancer","volume":"6","author":"Sabatier","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2019.01.033_bib28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm.2090","article-title":"Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer","volume":"16","author":"Li","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.cbi.2019.01.033_bib29","first-page":"6177","article-title":"Olanzapine, an atypical antipsychotic, inhibits survivin expression and sensitizes cancer cells to chemotherapeutic agents","volume":"37","author":"Sanomachi","year":"2017","journal-title":"Anticancer Res."},{"key":"10.1016\/j.cbi.2019.01.033_bib30","article-title":"Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomide","author":"Johannessen","year":"2018","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.cbi.2019.01.033_bib31","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.21873\/anticanres.11085","article-title":"Aripiprazole, an antipsychotic and partial dopamine agonist, inhibits cancer stem cells and reverses chemoresistance","volume":"36","author":"Suzuki","year":"2016","journal-title":"Anticancer Res."},{"key":"10.1016\/j.cbi.2019.01.033_bib32","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/onc.2016.292","article-title":"Aurora A kinase activates YAP signaling in triple-negative breast cancer","volume":"36","author":"Chang","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.cbi.2019.01.033_bib33","doi-asserted-by":"crossref","first-page":"10186","DOI":"10.1038\/ncomms10186","article-title":"A basal-like breast cancer-specific role for SRF-IL6 in YAP-induced cancer stemness","volume":"6","author":"Kim","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cbi.2019.01.033_bib34","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.humpath.2017.08.032","article-title":"Expression of YES-associated protein (YAP) and its clinical significance in breast cancer tissues","volume":"68","author":"Cao","year":"2017","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.cbi.2019.01.033_bib35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13046-018-0850-z","article-title":"Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1\/FAK signalling in breast cancer","volume":"37","author":"Shen","year":"2018","journal-title":"J. Exp. Clin. Canc. Res."},{"key":"10.1016\/j.cbi.2019.01.033_bib36","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/onc.2013.88","article-title":"SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma","volume":"33","author":"Mao","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.cbi.2019.01.033_bib37","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1073\/pnas.1216462110","article-title":"Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1","volume":"110","author":"Fan","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cbi.2019.01.033_bib38","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41419-018-0302-x","article-title":"EGFR-PI3K-PDK1 pathway regulates YAP signaling in hepatocellular carcinoma: the mechanism and its implications in targeted therapy","volume":"9","author":"Xia","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cbi.2019.01.033_bib39","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.canlet.2015.12.011","article-title":"Induction of CXCR2 ligands, stem cell-like phenotype, and metastasis in chemotherapy-resistant breast cancer cells","volume":"372","author":"Sharma","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cbi.2019.01.033_bib40","first-page":"339","article-title":"Stat3\/Oct-4\/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066","volume":"53","author":"Cheng","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cbi.2019.01.033_bib41","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3389\/fonc.2018.00337","article-title":"Phenotypic basis for matrix stiffness-dependent chemoresistance of breast cancer cells to doxorubicin","volume":"8","author":"Joyce","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.cbi.2019.01.033_bib42","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1158\/1078-0432.CCR-13-1854","article-title":"Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes\/YAP axis","volume":"20","author":"Touil","year":"2014","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.cbi.2019.01.033_bib43","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3892\/or.2012.2176","article-title":"Overexpression of Yes-associated protein confers doxorubicin resistance in hepatocellullar carcinoma","volume":"29","author":"Huo","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.cbi.2019.01.033_bib44","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4161\/cbt.24345","article-title":"Yes-associated protein (YAP) increases chemosensitivity of hepatocellular carcinoma cells by modulation of p53","volume":"14","author":"Bai","year":"2013","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.cbi.2019.01.033_bib45","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.18632\/oncotarget.23187","article-title":"Metformin synergistically suppress tumor growth with doxorubicin and reverse drug resistance by inhibiting the expression and function of P-glycoprotein in MCF7\/ADR cells and xenograft models","volume":"9","author":"Li","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.cbi.2019.01.033_bib46","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3892\/ijmm.2015.2217","article-title":"Metformin exerts anticancer effects through the inhibition of the Sonic hedgehog signaling pathway in breast cancer","volume":"36","author":"Fan","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.cbi.2019.01.033_bib47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.biopha.2018.03.031","article-title":"Metformin inhibits glioma cells stemness and epithelial-mesenchymal transition via regulating YAP activity","volume":"102","author":"Yuan","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2019.01.033_bib48","doi-asserted-by":"crossref","first-page":"46230","DOI":"10.18632\/oncotarget.10079","article-title":"Metformin mediates resensitivity to 5-fluorouracil in hepatocellular carcinoma via the suppression of YAP","volume":"7","author":"Tian","year":"2016","journal-title":"Oncotarget"}],"updated-by":[{"DOI":"10.1016\/j.cbi.2019.108812","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000}}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279718306215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279718306215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:52:01Z","timestamp":1757857921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279718306215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":48,"alternative-id":["S0009279718306215"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2019.01.033","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.cbi.2019.108812","asserted-by":"object"}]},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The antipsychotic chlorpromazine suppresses YAP signaling, stemness properties, and drug resistance in breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2019.01.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}